Latest Commercial Development News

Classic Minerals has taken a decisive step towards mining at its Forrestania project by issuing a formal Notice of Decision to Commence Mining for the Lady Ada and Lady Magdalene deposits, despite ongoing legal challenges.

Aland Equity Group (ASX: AEG) has locked in long-term funding rights over major NSW and ACT-area developments, marking a strategic pivot into property funds management with a pipeline exceeding 4,200 residential lots and 100,000sqm of commercial space.

MAAS Group Holdings reconfirms FY26 EBITDA guidance, reports 35% completion on a $200 million AI factory electrical contract, progresses $1.7 billion construction materials sale, and expands debt facilities to support growth.

Titomic Limited has landed a contract worth over AUD 1.2 million from Lufthansa Technik AG to supply additional cold spray equipment to its Hamburg facility, reinforcing its foothold in aerospace additive manufacturing.

Worley unveils a medium-term growth strategy through FY30 focused on expanding full project delivery, investing $70 million in AI, and leveraging strategic partnerships amid near-term geopolitical challenges.

Neurizon Therapeutics has gained ethics approval to start a Phase 1 trial of its NUZ-001 oral liquid formulation, aiming to ease treatment for ALS patients with swallowing difficulties.

BPH Global’s Indonesian unit has locked in a four-year MoU with ITBM to integrate student-driven operations and research at its Takalar coastal seaweed site, setting the stage for scaled commercial development and local collaboration.

ReNerve Limited reports a 79% jump in quarterly sales, secures key Asia-Pacific approvals, and progresses its nerve repair pipeline with the NervAlign Nerve Guide Matrix entering Stage 3 development.

Lake Resources made solid progress on the Exploitation Environmental Impact Assessment for its Kachi Lithium Brine Project, targeting approval in Q3 2026, while maintaining strong liquidity and strategic partnerships.

Bio-Gene Technology is progressing critical toxicology studies for Flavocide with a targeted APVMA submission in March 2027, while forging a strategic partnership to launch Qcide insecticides in Japan by late 2026.

Biome Australia has taken a significant step in its innovation journey by filing a patent for its next generation probiotic strain BMB18, with a clinical trial set to begin in Q4 FY26 in partnership with La Trobe University.

Macallum New Energy has successfully listed on the ASX and raised A$7.4 million to fund exploration in the Northern Perth Basin. The company is progressing a 66% complete Barberton 3D seismic survey and preparing a Condor 2D survey, positioning itself amid renewed regional drilling activity.